Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) announced its earnings results on Monday. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.44), Zacks reports. Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%.
Bioceres Crop Solutions Trading Up 2.2%
Shares of BIOX traded up $0.01 during trading on Monday, reaching $0.43. 275,527 shares of the company traded hands, compared to its average volume of 524,470. The company has a quick ratio of 0.70, a current ratio of 0.88 and a debt-to-equity ratio of 0.57. The stock has a 50-day simple moving average of $0.38 and a 200-day simple moving average of $0.44. Bioceres Crop Solutions has a twelve month low of $0.30 and a twelve month high of $2.19. The stock has a market cap of $27.07 million, a PE ratio of -0.11 and a beta of 0.44.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research note on Monday, July 13th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $2.00.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
